Home
TimeZone
   
Currency
   
Language
  HOME   STOCK MARKETS PORTFOLIO WATCHLIST ALERTS INDICES CONVERTER IR SERVICES MORE


Back
10 Last viewed shares   
 
Year in Brief
  Year in Brief
  REVENUE The consolidated revenue of the Group for the year 2018 amounted to approximately RMB 740,422,000, comparing to approximately RMB 497,694,000 for the ...
  Read more... 
Strategy & Goals
  Strategy & Goals
  Corporate Strategy Össur’s vision is to be the leading company in non-invasive orthopaedics. Össur’s business is improving people’s mobility through ...
  Read more... 
Company Presentation
  Company Presentation
  China Resources Medical Holdings Company Limited (referred as"CR Medical"or"group") is the strategic investment platform of China Resources Group in ...
  Read more... 
   

PHAXIAM Therapeutics

    Print this page Print this page    Send to a Friend E-mail this page to your friend    Disclaimer

SHARE DATA GRAPH TECHNICAL ANALYSIS
Select class of Share
PHAXIAM Therapeutics (FRK)‎  
Last 1,92      Change % 0,00 
Add to Portfolio
Add to Watchlist
Add to Alerts

10 LAST TRADES EUR
Time Last Volume
Displayed time is based on the time zone of your choice on Euroland.com
Refresh
ChartImage
 
QUOTES EUR
Time 2024-07-15
Last 1,92
Change % 0,00 
Change 0,00 
Bid/Ask 1,90 / 2,15
Open 1,92
High/Low 1,92 / 1,92
Volume 0
Previous Close 1,92
52 Weeks High 5,06
52 Weeks Low 1,88
52 Weeks % -
YTD %   -56,86 
Volatility 51,02
Beta 0,57
Correlation 0,13
MARKET DATA
Symbol 2E40
Market  Frankfurt
List  Open Market
Domestic Industry  Pharmaceutical & Healthcare
Euroland-Industry  Pharmaceuticals - other
Shares (mil)1 6,08
Market Cap (mil) 11,66
1 - Number of shares in specific class of share. Otherwise it is total number of shares issued.

INDICES
 -
Data delayed at least 15 minutes. From Hanoi & HoChiMinh data is real time. From Milan, Dublin & Tokyo data is as end of day.
Data provided by vwd group Switzerland AG & MOEX.

 
 
   Privacy Policy | Disclaimer | Set this page as your homepage| © Euroland.com 2000-2024